PUBLIC CONTRACT · 2014

Processo n.º 61/119-Medicamentos para doenças endocrinas

Contract value: €164,615.02
Signed on: 8 January 2014
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 1407504

PUBLISHED SUBJECT

Parties involved

Contracting body: Centro Hospitalar do Algarve, E. P. E.
Awardee: Lab pfizer; novartis; novo nordisk; merck skarp; merck; dilofar; Lab. vitoria
Place of performance: Portugal, Faro, Faro
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: Lab pfizer · Tax ID 500162166
Awardee: novartis · Tax ID 500063524
Awardee: novo nordisk · Tax ID 501485210
Awardee: merck skarp · Tax ID 500191360
Awardee: merck · Tax ID 500650870
Awardee: dilofar · Tax ID 500563004
Awardee: Lab. vitoria · Tax ID 500162220

Values and timeline

Contract price: €164,615.02
Procedure base price: €164,615.02
Total effective price: €164,615.02
Publication date: 17 March 2015
Award date: 8 January 2014
Signing date: 8 January 2014
Performance period: 360 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Not stated
CPV code: 33690000-3 - Medicamentos vários
Legal basis: Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL 18/2008)
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 1410882

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts